To Study The Predictors of Lymphedema in Ipsilateral Arm in Patients treated with Modified Radical Mastectomy for Breast Cancer
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/08/056411
- Lead Sponsor
- AIIMS RISHIKESH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All Female Patients >18 years of age with Biopsy proven Infiltrating Ductal Carcinoma (Adenocarcinoma) Breast
cancer who underwent Modified Radical Mastectomy
2.Giving Informed consent for being included in the study
Exclusion Criteria
Preexisting Lymphedema of the Ipsilateral arm.
Axillary Vein thrombosis
Metastatic Breast cancer
Bilateral breast cancer
Recurrent breast cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the Patient factors & Tumour factors as Predictors of Arm Lymphedema in breast cancer patients undergoing Modified Radical Mastectomy <br/ ><br>Timepoint: To study the Patient factors & Tumour factors as Predictors of Arm Lymphedema in breast cancer patients undergoing Modified Radical Mastectomy <br/ ><br> <br/ ><br>Lymphedema/arm size will be recorded at baseline 1 month, 3 months and 6 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method To find the Prevalence of Arm Lymphedema in patients who have undergone Modified Radical Mastectomy. <br/ ><br>Timepoint: at end of study, 18 months;Compare prevalence of Arm Lymphedema in patients who have undergone Modified Radical Mastectomy among different stages of Breast cancer. <br/ ><br>Timepoint: at end of study, 18 months